Watch an interview with Dr. David Shulkin, U.S. Secretary of Veterans Affairs, at the 2017 Cohen Veterans Care Summit

Dr. Shulkin speaks about research and collaboration at the 2017 Cohen Veterans Care Summit: "It starts with good diagnostic abilities which is lacking in our clinical inventory and so developing biomarkers is something that we are very interested in doing because we think there is a strong need out there."

Share this article:

More from CVB

Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder

New meta-analysis builds upon PTSD genetics research, providing a foundation for the development of precision therapies

Driving Progress: TBI Action Alliance Launches Multi-Pronged Initiative to Speed Development of Diagnostic and Therapeutic Solutions for Traumatic Brain Injury

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.